The primary outcome variable was the difference in anaerobic bacterial load of the implant surface before and after mechanical and chemical debridement and decontamination.
Results : Implant decontamination with phosphoric acid (2)
author: Diederik F M Hentenaar, Yvonne C M De Waal, Hans Strooker, Henny J A Meijer, Arie-Jan Van Winkelhoff, Gerry M Raghoebar | publisher: drg. Andreas Tjandra, Sp. Perio, FISID
Clinical outcomes
Descriptive statistics of the clinical outcomes at baseline and follow-up are depicted in Table 4. At 3-month follow-up, 75% of the implants (66.7% of the patients) in the control group and 63.3% of the implants (53.8% of the patients) in the test group showed no clinical signs of inflammation (PPD ≤4 mm without bleeding and/or suppuration on probing) (Table 4). The results from the multilevel analyses regarding the effects of the intervention on BoP, SoP, and PPD are shown in Table 5. No significant differences in BoP, SoP, and mean PPD were detected between control and test group at 3 months after surgery, neither in the “crude” nor in the “adjusted” analysis.
Serial posts:
- Implant decontamination with phosphoric acid
- Background : Implant decontamination with phosphoric acid
- Methods : Implant decontamination with phosphoric acid
- Interventions : Implant decontamination with phosphoric acid
- Outcomes : Implant decontamination with phosphoric acid
- Randomization : Implant decontamination with phosphoric acid
- Statistical analysis : Implant decontamination with phosphoric acid
- Results : Implant decontamination with phosphoric acid (1)
- Results : Implant decontamination with phosphoric acid (2)
- Discussion : Implant decontamination with phosphoric acid (1)
- Discussion : Implant decontamination with phosphoric acid (2)
- Discussion : Implant decontamination with phosphoric acid (3)
- References : Implant decontamination with phosphoric acid
- Table 1 Characteristics of included patients/implants
- Table 2 Log-transformed mean bacterial anaerobic counts
- Table 3 Log-transformed mean bacterial anaerobic counts
- Table 4 Descriptive statistics of clinical parameters
- Table 5 Average differences in BoP, SoP, and PPD between the control and test group at 3-month follow-up
- Figure 1. Flow diagram